XML 14 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Balance Sheets - EUR (€)
€ in Millions
Jun. 30, 2025
Dec. 31, 2024
Assets    
Property, plant and equipment owned € 9,574 € 10,091
Right-of-use assets 1,433 1,510
Goodwill 40,283 43,384
Other intangible assets 20,431 22,629
Investments accounted for using the equity method 3,563 316
Other non-current assets 4,109 3,753
Non-current income tax assets 541 560
Deferred tax assets 8,008 7,967
Non-current assets 87,942 90,210
Current assets 37,017 42,588
Inventories 9,618 9,431
Accounts receivable 7,810 7,677
Other current assets 3,595 3,826
Current income tax assets 397 724
Cash and cash equivalents 15,359 7,441
Assets held for sale 238 13,489
Total assets 124,959 132,798
Equity and liabilities    
Equity attributable to equity holders of Sanofi 70,008 77,507
Equity attributable to non-controlling interests 271 350
Total equity 70,279 77,857
Long-term debt 13,200 11,791
Non-current lease liabilities 1,524 1,645
Non-current liabilities related to business combinations and to non-controlling interests 564 [1] 569
Non-current provisions and other non-current liabilities 7,116 8,096
Non-current income tax liabilities 1,502 1,512
Deferred tax liabilities 1,715 2,166
Non-current liabilities 25,621 25,779
Accounts payable 7,075 7,551
Current liabilities related to business combinations and to non-controlling interests 0 [1] 72
Current provisions and other current liabilities 13,697 14,241
Current income tax liabilities 724 697
Current lease liabilities 252 261
Short-term debt and current portion of long-term debt 7,309 4,209
Current liabilities 29,059 29,162
Liabilities related to assets held for sale 2 2,131
Total equity and liabilities € 124,959 € 132,798
[1] As of January 1, 2025, this comprised a non-current portion of €569 million and a current portion of €72 million.